The Hierarchy of Evidence Pyramid

Total Page:16

File Type:pdf, Size:1020Kb

The Hierarchy of Evidence Pyramid The Hierarchy of Evidence Pyramid Available from: https://www.researchgate.net/figure/Hierarchy-of-evidence-pyramid-The-pyramidal-shape-qualitatively-integrates-the- amount-of_fig1_311504831 [accessed 12 Dec, 2019] Available from: https://journals.lww.com/clinorthop/Fulltext/2003/08000/Hierarchy_of_Evidence__From_Case_Reports_to.4.aspx [accessed 14 March 2020] CLINICAL ORTHOPAEDICS AND RELATED RESEARCH Number 413, pp. 19–24 © 2003 Lippincott Williams & Wilkins, Inc. Hierarchy of Evidence: From Case Reports to Randomized Controlled Trials Brian Brighton, MD*; Mohit Bhandari, MD, MSc**; Downloaded from https://journals.lww.com/clinorthop by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3oaxD/v Paul Tornetta, III, MD†; and David T. Felson, MD* In the hierarchy of research designs, the results This hierarchy has not been supported in two re- of randomized controlled trials are considered cent publications in the New England Journal of the highest level of evidence. Randomization is Medicine which identified nonsignificant differ- the only method for controlling for known and ences in results between randomized, controlled unknown prognostic factors between two com- trials, and observational studies. The current au- parison groups. Lack of randomization predis- thors provide an approach to organizing pub- poses a study to potentially important imbal- lished research on the basis of study design, a hi- ances in baseline characteristics between two erarchy of evidence, a set of principles and tools study groups. There is a hierarchy of evidence, that help clinicians distinguish ignorance of evi- with randomized controlled trials at the top, con- dence from real scientific uncertainty, distin- trolled observational studies in the middle, and guish evidence from unsubstantiated opinions, uncontrolled studies and opinion at the bottom. and ultimately provide better patient care. In the hierarchy of research designs, the results of randomized controlled trials are considered From the *Boston University School of Medicine and 26 School of Public Health, Boston University, Boston, MA; the highest level of evidence. Randomization the **Department of Clinical Epidemiology and Biosta- is the only method for controlling for known H2r74b7+NAL/T0XV2hVa0sPFhqAJ/HU+hxuW0= on 03/19/2020 tistics, McMaster University, Hamilton, Ontario, Canada; and unknown prognostic factors between two and the †Department of Orthopaedic Surgery, Boston Uni- comparison groups.1, 26 Lack of randomization versity, Boston, MA. predisposes a study to potentially important Reprint requests to Mohit Bhandari, MD, McMaster Uni- imbalances in baseline characteristics between versity Health Sciences Center, Department of Clinical Epidemiology and Biostatistics, Health Science Centre, two study groups. The role of nonrandomized Room 2C3, 1200 Main Street West, Hamilton, Ontario, (observational) studies in evaluating treat- L8N 3Z5 Canada. Phone: 905–525-9140 ext. 22825; Fax: ments is an area of continued debate: deliber- 905–524-3841; E-mail: [email protected]. ate choice of the treatment for each patient DOI: 10.1097/01.blo.0000079323.41006.12 19 Clinical Orthopaedics 20 Brighton et al and Related Research implies that observed outcomes may be caused mate goal of judging whether a particular ex- by differences among people being given the posure causes or prevents disease. Analytic two treatments, rather than the treatments design strategies include observational stud- alone. Unrecognized confounding factors can ies, such as case-control and cohort studies, interfere with attempts to correct for identified and clinical trials. The difference between the differences between groups. There has been two types of analytic studies is the role that the considerable debate about whether the results investigator plays in each of the studies.20 In of nonrandomized studies are consistent with the observational study, the investigator sim- the results of randomized controlled trials.3, 10, ply observes the natural course of events. In 12–14, 21, 22, 28 Nonrandomized studies, or obser- the randomized controlled trial, the investiga- vational studies, have been reported to overes- tor assigns the intervention or treatment. Al- timate or underestimate treatment effects.21, 22 though an in-depth discussion on assessing These considerations have supported a hi- the methodologic quality of each particular erarchy of evidence, with randomized con- study is beyond the scope of the current study, trolled trials at the top, controlled observa- the basic strengths and limitations of each re- tional studies in the middle, and uncontrolled search strategy will be addressed. studies and opinion at the bottom. However, Levels of Evidence these findings have not been supported in two recent publications in the New England Jour- Investigators have attempted to minimize po- nal of Medicine that identified nonsignificant tentially harming patients by basing clinical differences in results between randomized, decisions of the sorts of evidence that are controlled trials and observational studies.3, 13 least likely to be wrong. Two studies defined The current authors provide an approach to what was thought to be the evidence provid- organizing published research on the basis of ing the least biased estimate of the effect of an study design, a hierarchy of evidence. The key intervention: a systematic review document- features and the advantages and disadvantages ing homogeneity in results of a large number of specific study designs will be addressed. of high-quality randomized controlled trials The concepts presented hopefully will enable (randomized with concealment, blinded, com- clinicians and healthcare personnel to practice plete followup, and intention-to-treat analy- 8,25 in the context of evidence-based orthopaedics. sis). This was termed Level 1 Evidence. These investigators additionally categorized Types of Study Design studies of an intervention based on an increas- The types of study designs used in clinical re- ing degree of potential bias: systematic re- search can be classified broadly according to views with randomized controlled trials that whether the study focuses on describing the reveal differences in treatment effect (hetero- distributions or characteristics of a disease or geneity); individual high-quality randomized elucidating its determinants. controlled trials (Level IB evidence); less rig- Descriptive studies are concerned with de- orous randomized controlled trials; cohort or scribing the general characteristics of the dis- observational studies (Level 2 evidence); tribution of a disease, particularly in relation case-control studies (Level 3 evidence); case to person, place, and time. Cross-sectional series (Level 4 evidence), and expert opinion studies, case reports, and case series represent (Level 5 evidence).23 Based on the various types of descriptive studies. Information on levels of evidence of a particular treatment, each can provide clues leading to the genera- grades of recommendation can be deter- tion of a hypothesis that is consistent with ex- mined.25,26 For example, the following grades isting knowledge of disease occurrence. of recommendations have been proposed: (1) Analytic studies focus on determinants of a Grade A, consistent Level 1 studies; (2) Grade disease by testing a hypothesis with the ulti- B, consistent Level 2 or Level 3 studies; (3) Number 413 August, 2003 Hierarchy of Evidence 21 Grade C, Level 4 studies; and (4) Grade D, with those without the outcome. Although the Level 5 studies.25,26 odds ratio can be used to estimate the relative Case Report and Case Series risk, it cannot provide information about ex- cess risk. The case-control study can be useful Case reports are an uncontrolled, descriptive in studying rare outcomes, outcomes with study design involving an intervention and out- multiple potential etiologic factors, or looking come with a detailed profile of one patient. An at outcomes that take a considerable length of early example from the orthopaedic literature time to develop. Additionally, they can be done of a case report is Birkett’s 1869 description of in a short time with small sample sizes, and for 7 a fracture-dislocation of the hip. Expansion of less money than other types of studies. How- the individual case report to include multiple ever, because the information usually is col- patients with an outcome of interest is a case lected from patients or their hospital records, series. In 1981, a famous case series involving data may be inaccurate because of the effect of five homosexual men in Los Angeles, CA with recall bias and measurement bias. Pneumocystis carinii between 1980 and 1981 marked the beginning of the AIDS epidemic in Cohort Study the United States.9 Although descriptive stud- The term cohort comes from the Roman word ies are limited in their design to make causal in- for a group of soldiers that marched into battle ferences about the relationship between risk together.15 In the cohort study design, the cohort factors and an outcome of interest, they are represents a group of people followed up with helpful in developing a hypothesis that can be time to see whether an outcome of interest de- tested using an analytic study design. velops. Ideally this group meets a level of cer- Case-Control Study tain predetermined criteria representative of a population of interest and is followed with well- One type of observational study is the case- defined outcome variables. The Framingham control study that
Recommended publications
  • Cebm-Levels-Of-Evidence-Background-Document-2-1.Pdf
    Background document Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) Levels of Evidence Introduction The OCEBM Levels of Evidence was designed so that in addition to traditional critical appraisal, it can be used as a heuristic that clinicians and patients can use to answer clinical questions quickly and without resorting to pre-appraised sources. Heuristics are essentially rules of thumb that helps us make a decision in real environments, and are often as accurate as a more complicated decision process. A distinguishing feature is that the Levels cover the entire range of clinical questions, in the order (from top row to bottom row) that the clinician requires. While most ranking schemes consider strength of evidence for therapeutic effects and harms, the OCEBM system allows clinicians and patients to appraise evidence for prevalence, accuracy of diagnostic tests, prognosis, therapeutic effects, rare harms, common harms, and usefulness of (early) screening. Pre-appraised sources such as the Trip Database (1), (2), or REHAB+ (3) are useful because people who have the time and expertise to conduct systematic reviews of all the evidence design them. At the same time, clinicians, patients, and others may wish to keep some of the power over critical appraisal in their own hands. History Evidence ranking schemes have been used, and criticised, for decades (4-7), and each scheme is geared to answer different questions(8). Early evidence hierarchies(5, 6, 9) were introduced primarily to help clinicians and other researchers appraise the quality of evidence for therapeutic effects, while more recent attempts to assign levels to evidence have been designed to help systematic reviewers(8), or guideline developers(10).
    [Show full text]
  • Causality in Medicine with Particular Reference to the Viral Causation of Cancers
    Causality in medicine with particular reference to the viral causation of cancers Brendan Owen Clarke A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy of UCL Department of Science and Technology Studies UCL August 20, 2010 Revised version January 24, 2011 I, Brendan Owen Clarke, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. ................................................................ January 24, 2011 2 Acknowledgements This thesis would not have been written without the support and inspiration of Donald Gillies, who not only supervised me, but also introduced me to history and philosophy of science in the first instance. I have been very privileged to be the beneficiary of so much of his clear thinking over the last few years. Donald: thank you for everything, and I hope this thesis lives up to your expectations. I am also extremely grateful to Michela Massimi, who has acted as my second supervisor. She has provided throughout remarkably insightful feedback on this project, no matter how distant it is from her own research interests. I’d also like to thank her for all her help and guidance on teaching matters. I should also thank Vladimir Vonka for supplying many important pieces of both the cervical cancer history, as well as his own work on causality in medicine from the perspective of a real, working medical researcher. Phyllis McKay-Illari provided a critical piece of the story, as well as many interesting and stim- ulating discussions about the more philosophical aspects of this thesis.
    [Show full text]
  • A Meta-Review of Transparency and Reproducibility-Related Reporting Practices in Published Meta- Analyses on Clinical Psychological Interventions (2000-2020)
    A meta-review of transparency and reproducibility-related reporting practices in published meta- analyses on clinical psychological interventions (2000-2020). Rubén López-Nicolás1, José Antonio López-López1, María Rubio-Aparicio2 & Julio Sánchez- Meca1 1 Universidad de Murcia (Spain) 2 Universidad de Alicante (Spain) Author note: This paper has been published at Behavior Research Methods. The published version is available at: https://doi.org/10.3758/s13428-021-01644-z. All materials, data, and analysis script coded have been made publicly available on the Open Science Framework: https://osf.io/xg97b/. Correspondence should be addressed to Rubén López-Nicolás, Facultad de Psicología, Campus de Espinardo, Universidad de Murcia, edificio nº 31, 30100 Murcia, España. E-mail: [email protected] 1 Abstract Meta-analysis is a powerful and important tool to synthesize the literature about a research topic. Like other kinds of research, meta-analyses must be reproducible to be compliant with the principles of the scientific method. Furthermore, reproducible meta-analyses can be easily updated with new data and reanalysed applying new and more refined analysis techniques. We attempted to empirically assess the prevalence of transparency and reproducibility-related reporting practices in published meta-analyses from clinical psychology by examining a random sample of 100 meta-analyses. Our purpose was to identify the key points that could be improved with the aim to provide some recommendations to carry out reproducible meta-analyses. We conducted a meta-review of meta-analyses of psychological interventions published between 2000 and 2020. We searched PubMed, PsycInfo and Web of Science databases. A structured coding form to assess transparency indicators was created based on previous studies and existing meta-analysis guidelines.
    [Show full text]
  • Evidence Based Policymaking’ in a Decentred State Abstract
    Paul Cairney, Professor of Politics and Public Policy, University of Stirling, UK [email protected] Paper accepted for publication in Public Policy and Administration 21.8.19 Special Issue (Mark Bevir) The Decentred State The myth of ‘evidence based policymaking’ in a decentred state Abstract. I describe a policy theory story in which a decentred state results from choice and necessity. Governments often choose not to centralise policymaking but they would not succeed if they tried. Many policy scholars take this story for granted, but it is often ignored in other academic disciplines and wider political debate. Instead, commentators call for more centralisation to deliver more accountable, ‘rational’, and ‘evidence based’ policymaking. Such contradictory arguments, about the feasibility and value of government centralisation, raise an ever-present dilemma for governments to accept or challenge decentring. They also accentuate a modern dilemma about how to seek ‘evidence-based policymaking’ in a decentred state. I identify three ideal-type ways in which governments can address both dilemmas consistently. I then identify their ad hoc use by UK and Scottish governments. Although each government has a reputation for more or less centralist approaches, both face similar dilemmas and address them in similar ways. Their choices reflect their need to appear to be in control while dealing with the fact that they are not. Introduction: policy theory and the decentred state I use policy theory to tell a story about the decentred state. Decentred policymaking may result from choice, when a political system contains a division of powers or a central government chooses to engage in cooperation with many other bodies rather than assert central control.
    [Show full text]
  • 1 Lessons from the Evidence on Evidence-Based Policy Richard D. French Introduction What Can We Learn from the Evidence on Evide
    Lessons from the Evidence on Evidence-based Policy Richard D. French Introduction What can we learn from the evidence on evidence-based policy (EBP)? We cannot do a randomized controlled test, as dear to the hearts of many proponents of EBP as that method may be. Much of the “evidence” in question will not meet the standards of rigour demanded in the central doctrine of EBP, but we are nevertheless interested in knowing, after a number of years as an idea in good currency, what we have gathered from the pursuit of EBP. In one of the most important surveys of research use, Sandra Nutley, Isabel Walter and Huw Davies (Nutley et al 2007, 271) note that: As anyone working in the field of research use knows, a central irony is the only limited extent to which evidence advocates can themselves draw on a robust evidence base to support their convictions that greater evidence use will ultimately be beneficial to public services. Our conclusions…are that we are unlikely any time soon to see such comprehensive evidence neatly linking research, research use, and research impacts, and that we should instead be more modest about what we can attain through studies that look for these. If then, we want to pursue our interest in the experience of EBP, we need to be open- minded about the sources we use. A search for “evidence-based policy” on the PAIS database produced 132 references in English. These references, combined with the author’s personal collection developed over the past several years, plus manual searches of the bibliographies of the books, book chapters and articles from these two original sources, produced around 400 works on EBP.
    [Show full text]
  • Evidence for Improved Policy Making: from Hierarchies to Appropriateness
    Working Paper # 2 ‘Good’ evidence for improved policy making: from hierarchies to appropriateness Sudeepa Abeysinghe, Justin Parkhurst June 2013 London School of Hygiene and Tropical Medicine GRIP-Health Programme www.lshtm.ac.uk/groups/griphealth The Getting Research Into Policy in Health (GRIP-Health) project is supported by a grant from the European Research Council (Project ID# 282118). The views expressed here are solely those of the authors and do not necessarily reflect the funding body or the host institution. Summary Within the field of public health, and increasingly across other areas of social policy, there are widespread calls to increase or improve the use of evidence for policy making. Often these calls rest on an assumption that improved evidence utilisation will be a more efficient or effective means of achieving social goals. Yet, a clear elucidation of what can be considered ‘good evidence’ for policy use is rarely articulated. Many of the current discussions of best practice in the health policy sector derive from the evidence-based medicine (EBM) movement, embracing the ‘hierarchy of evidence’ in framing the selection of evidence – a hierarchy that places experimental trials as preeminent in terms of methodological quality. However, there are a number of difficulties associated with applying EBM methods of grading evidence onto policy making. Numerous public health authors have noted that the hierarchy of evidence is a judgement of quality specifically developed for measuring intervention effectiveness, and as such it cannot address other important health policy considerations such as affordability, salience, or public acceptability (Petticrew and Roberts, 2003). Social scientists and philosophers of knowledge have illustrated other problems in the direct application of the hierarchy of evidence to guide policy.
    [Show full text]
  • Meta-Analysis Understanding Systematic Reviews
    Downloaded from adc.bmjjournals.com on 27 September 2006 Understanding systematic reviews and meta-analysis A K Akobeng Arch. Dis. Child. 2005;90;845-848 doi:10.1136/adc.2004.058230 Updated information and services can be found at: http://adc.bmjjournals.com/cgi/content/full/90/8/845 These include: References This article cites 11 articles, 10 of which can be accessed free at: http://adc.bmjjournals.com/cgi/content/full/90/8/845#BIBL Rapid responses You can respond to this article at: http://adc.bmjjournals.com/cgi/eletter-submit/90/8/845 Email alerting Receive free email alerts when new articles cite this article - sign up in the box at the service top right corner of the article Topic collections Articles on similar topics can be found in the following collections Systematic reviews (incl meta-analyses): examples (338 articles) Notes To order reprints of this article go to: http://www.bmjjournals.com/cgi/reprintform To subscribe to Archives of Disease in Childhood go to: http://www.bmjjournals.com/subscriptions/ Downloaded from adc.bmjjournals.com on 27 September 2006 837 EVIDENCE BASED CHILD HEALTH 1 Principles of evidence based medicine A K Akobeng ............................................................................................................................... Arch Dis Child 2005;90:837–840. doi: 10.1136/adc.2005.071761 Health care professionals are increasingly required to base preferences, and should also incorporate exper- tise in performing clinical history and physical clinical decisions on the best available evidence. Evidence examination. Figure 1 illustrates a typical flow based medicine (EBM) is a systematic approach to clinical chart of EBM, depicting how knowledge and problem solving which allows the integration of the best experience may be integrated with patients’ preferences and available evidence in the making available research evidence with clinical expertise and of clinical decisions.
    [Show full text]
  • Evidence, Hierarchies, and Typologies: Horses for Courses M Petticrew, H Roberts
    527 J Epidemiol Community Health: first published as 10.1136/jech.57.7.527 on 1 July 2003. Downloaded from THEORY AND METHODS Evidence, hierarchies, and typologies: horses for courses M Petticrew, H Roberts ............................................................................................................................. J Epidemiol Community Health 2003;57:527–529 Debate is ongoing about the nature and use of evidence criteria that are used to appraise public health in public health decision making, and there seems to be interventions.6 This provided a valuable guide to the other types of public health knowledge that an emerging consensus that the “hierarchy of evidence” are needed to guide interventions, and also may be difficult to apply in other settings. It may be outlined the role of different types of research unhelpful however to simply abandon the hierarchy based information; particularly observational and qualitative data. At its heart is a recognition that without having a framework or guide to replace it. One the hierarchy of evidence is a difficult construct to such framework is discussed. This is based around a apply in evidence based medicine, and even more matrix, and emphasises the need to match research so in public health, and the paper points to the continuing debate about the appropriateness of questions to specific types of research. This emphasis on relying on study design as a marker for the cred- methodological appropriateness, and on typologies ibility of evidence. Our paper further pursues this rather than hierarchies of evidence may be helpful in issue of the hierarchy of evidence, and advocates its revision on two main grounds. It also suggests organising and appraising public health evidence.
    [Show full text]
  • GRADE Judging the Applicability and Strength of Evidence in Health Technology Assessments (Htas)
    GRADE Judging the applicability and strength of evidence in Health Technology Assessments (HTAs) Linda Long and Chris Hyde STEPS in a Systematic Review • Ask the question • Get the stuff – SEARCH • Check the stuff find appraise act – APPRAISAL • Synthesise the stuff – what does it mean? – meta-analysis (quantitative data) – meta-synthesis (qualitative data) • Apply in the decision Using evidence from systematic reviews • The endpoint of a systematic review is: – A summary of the evidence – An estimate of effect for various outcomes • We need to make a judgement on the strength of evidence across all studies for each important outcome • Guideline developers can use this judgement to formulate their recommendation(s) and consider the direction (for or against) and strength (strong or weak) of their recommendation(s) GRADE - Grading of Recommendations, Assessment, Development and Evaluation • The GRADE approach is a transparent system for grading the quality of evidence in systematic reviews • GRADE Working Group (www.gradeworkinggroup.org) – International group of guideline developers, methodologists and clinicians from around the world (>100 contributors) – since 2000 What is GRADE? • GRADE describes the extent to which you can be confident that an estimate of effect is near the true value for each outcome, across all studies • When judging the quality of a body of evidence, the assessment considers several factors , including The Risk of Bias of each included study • Other factors for assessing quality are: – imprecision, inconsistency,
    [Show full text]
  • Building a Foundation for an Evidence-Based Approach to Practice: Teaching Basic Concepts to Undergraduate Freshman Students
    Building a Foundation for an Evidence-Based Approach to Practice: Teaching Basic Concepts to Undergraduate Freshman Students HELEN K. BURNS,PHD, RN,* AND SUSAN M. FOLEY,PHD, RN* The University of Pittsburgh School of Nursing intro- and deaths that occur as a result of errors in care duced evidence-based practice (EBP) into the fresh- (Committee on Quality Healthcare in America man-level curriculum this year. This article describes [CQHA], IOM, 1999). In Crossing the Quality the reasons behind this decision, the development of the curriculum, the specific EBP content, and the Chasm: A New Health System for the 21st Century, student assignments. The introduction of EBP into the the IOM discussed reform measures necessary to first-level nursing curriculum has proven to be suc- ensure quality care delivery (CQHA, IOM, 2001). cessful; consideration is even being given to expand- Safer, high-quality care must come from redesigned ing the EBP content. (Index words: Evidence-based systems of care, ones that deliver state-of-the-art practice; Critical thinking; Research utilization; Bac- calaureate education; Curriculum) J Prof Nurs 21: health care (CQHA,IOM,2001). This report 351-357, 2005. A 2005 Elsevier Inc. All rights reserved. disparages the 20-year gap existing between research generation and implementation of findings into practice; it supports the use of information technol- HE UNIVERSITY OF Pittsburgh School of ogy and EBP as essential factors for health care T Nursing decided to incorporate evidence-based reform. More importantly, this report recommended practice (EBP) into its freshman-level curriculum, that there be a meeting of an interdisciplinary team of beginning with the 2004–2005 freshmen class.
    [Show full text]
  • USING RESEARCH EVIDENCE a Practice Guide 1
    USING RESEARCH EVIDENCE A Practice Guide 1 USING RESEARCH EVIDENCE A Practice Guide ACKNOWLEDGEMENTS This guide was written by Jonathan Breckon, edited by Isobel Roberts and produced by Nesta’s Innovation Skills team. Thank you to the following for their comments, suggestions and help with this guide: Helen Anderson (Policy Profession, Civil Service Learning); Jonathan Bamber (Nesta); Albert Bravo- Biosca (Nesta); Professor Paul Cairney (University of Stirling); Michael O’Donnell (BOND); Triin Edovald (Nesta); Caroline Kenny (Parliamentary Office for Science and Technology); Geoff Mulgan (Nesta); Tony Munton (Centre for Evidence Based Management and RTK Ltd); Nicky Miller (College of Policing); Helen Mthiyane (Alliance for Useful Evidence); Jonathan Sharples (Education Endowment Foundation); Louise Shaxson (Overseas Development Institute); Howard White (Campbell Collaboration). We would also like to thank all the participants and partners in our Evidence Masterclasses during 2014-15, including Civil Service Learning, ACEVO (Association of Chief Executives of Voluntary Organisations), Scottish Council for Voluntary Organisations, SOLACE and the Welsh Government Policy Profession. The views do not, however, necessarily reflect the suggestions made by these individuals or their affiliated organisations. Any errors in the report remain the author’s own. About the Alliance for Useful Evidence The Alliance champions the use of evidence in social policy and practice. We are an open–access network of 2,500 individuals from across government, universities, charities, business and local authorities in the UK and internationally. Membership is free. To sign up visit: alliance4usefulevidence.org/join Nesta’s Practice Guides This guide is part of a series of Practice Guides developed by Nesta’s Innovation Skills team.
    [Show full text]
  • The Politics of Evidence: from Evidence- Based Policy to the Good Governance of Evidence
    Justin Parkhurst The politics of evidence: from evidence- based policy to the good governance of evidence Book (Published version) Original citation: Parkhurst, Justin (2017) The politics of evidence: from evidence-based policy to the good governance of evidence. Routledge Studies in Governance and Public Policy. Routledge, Abingdon, Oxon, UK. ISBN 9781138939400 Reuse of this item is permitted through licensing under the Creative Commons: © 2017 The Author CC BY-NC-ND This version available at: http://eprints.lse.ac.uk/68604/ Available in LSE Research Online: December 2016 LSE has developed LSE Research Online so that users may access research output of the School. Copyright © and Moral Rights for the papers on this site are retained by the individual authors and/or other copyright owners. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE Research Online website. ‘This book is a marvellous interdisciplinary synthesis, grounded in case examples and at once critical and constructive. As such, it is both instructive for policy practitioners as well as moving the scholarship of the field forward.’ –Vivian Lin, Professor of Public Health, La Trobe University, Australia ‘This is essential reading for anybody working on the smarter use of evidence by government. It catalogues the many biases twisting how research is used by policymakers. It also addresses a vital challenge in our sector – a lack of legitimacy. As well as the academic rigour of this book, there are practical tips on what we can do about these problems, and lessons from across the globe showing where we get it wrong – and how we might get it right.’ – Jonathan Breckon, Head of the Alliance for Useful Evidence, UK ‘This important book goes well beyond standard analyses of evidence informed policy with detailed discussions of the politics of evidence and the political origins (and the cognitive psychology) of bias in the use of research evidence.
    [Show full text]